Skip to main content
. 2011 Sep 17;79(4):729–747. doi: 10.3797/scipharm.1107-19

Fig. 5.

Fig. 5

Lowest-energy orientation of the π–π complex between doxorubicin and caffeine. (A) Face-to face orientation of caffeine (ball and spoke model) in its lowest-energy orientation with doxorubicin (tube model). (B) Molecular dipoles of doxorubicin (top) and caffeine (bottom). (C) LUMO of doxorubicin (top) and HOMO of caffeine (bottom). (D) Frontier molecular orbital overlap of caffeine with doxorubicin in the lowest-energy orientation. (E) Electrostatic potential maps of doxorubicin (top) and caffeine (bottom). (F) Electrostatic potential map of the lowest-energy π–π complex between doxorubicin and caffeine.